Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/2000
09/05/2000CA2082928C Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
09/05/2000CA2047686C Dietary supplement for insulin-resistant diabetics
09/05/2000CA2047685C Purified insulin mediators and purification process for same
08/2000
08/31/2000WO2000050641A1 T CELL RECEPTOR Vβ-Dβ-Jβ SEQUENCE AND METHODS FOR ITS DETECTION
08/31/2000WO2000050639A2 Gene sequence variations with utility in determining the treatment of disease
08/31/2000WO2000050580A2 Composition, methods and reagents for the synthesis of a soluble form of human phex
08/31/2000WO2000050562A2 Dna encoding snorf25 receptor
08/31/2000WO2000050456A2 Covalently bridged insulin dimers
08/31/2000WO2000050434A1 Malto-oligosaccharide derivatives and uses thereof
08/31/2000WO2000050429A1 Drugs containing phosphoric acid derivatives as the active ingredient
08/31/2000WO2000050403A1 N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance
08/31/2000WO2000050400A1 2-aminopyridines containing fused ring substituents
08/31/2000WO2000050392A1 2-mercaptocarboxylic acid derivatives
08/31/2000WO2000050090A2 Dry acid-chitosan complexes
08/31/2000WO2000050067A1 Method and composition for the regulation of hepatic and extrahepatic production of insulin-like growth factor-1
08/31/2000WO2000049896A1 Dietary compositions and methods
08/31/2000WO2000033667A3 Bioflavonoids, anthocyanins and phenol compounds from cherries as antioxidants
08/31/2000WO2000027410A3 Composition and method for increasing weight gain and feed efficiency
08/31/2000WO2000012074A3 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
08/31/2000DE19908539A1 Polycyclische 2-Amino-Dihydrothiazolsysteme, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Polycyclic 2-amino-Dihydrothiazolsysteme, processes for their preparation and their use as medicaments
08/31/2000DE19908537A1 Verwendung von polycyclischen 2-Amino-Thiazol Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas Use of 2-amino-thiazole polycyclic systems for the production of medicaments for the prophylaxis or treatment of obesity
08/31/2000DE19908536A1 Polycyclische Thiazol-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Polycyclic thiazol-2-ylidene amines, process for their preparation and their use as medicaments
08/31/2000DE19908533A1 Polycyclische Thiazol-Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen Polycyclic thiazole systems, processes for their preparation and pharmaceutical compositions containing these compounds
08/31/2000DE19908041A1 Kovalent verbrückte Insulindimere Covalently bridged insulin dimers
08/31/2000CA2366943A1 Dry acid-chitosan complexes
08/31/2000CA2362906A1 Dna encoding snorf25 receptor
08/31/2000CA2362533A1 Gene sequence variations with utility in determining the treatment of disease
08/31/2000CA2362099A1 T cell receptor v.beta.-d.beta.-j.beta. sequence and methods for its detection
08/30/2000EP1031347A1 Transnasal transport/immunisation with highly adaptable carriers
08/30/2000EP1030915A1 A novel gene and uses therefor
08/30/2000EP1030911A1 Human aspartic proteases
08/30/2000EP1030845A1 Heterocyclic compounds having mmp and tnf inhibitory activity
08/30/2000EP1030682A1 Preparations for the treatment of metabolic syndrome containing human growth hormone in combination with a cortisol synthesis inhibitor
08/30/2000EP1030665A1 Therapeutic uses of quinoline derivatives
08/30/2000EP1030658A1 Method of building and maintaining bone
08/30/2000EP1030557A1 Protein delivery by secretory gland expression
08/30/2000EP0836606B1 Condensed thiazole derivatives, having 5-ht receptor affinity
08/30/2000EP0783315B1 Hydration compositions for human or animal bodies
08/30/2000EP0612246B1 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
08/30/2000EP0584290B1 Endothelin antagonists
08/30/2000CN1265035A Method for inhibiting bone resorption
08/30/2000CN1265033A Certain diarylimidaozle derivatives, new class of NPY speific ligands
08/30/2000CN1265032A Therapeutic and dietary compsns. containing essential fatty acids and bioactive disulphides
08/30/2000CN1264704A Novel spiro imidazoline compounds, their prepn. method and medicinal compsns. containing same
08/30/2000CN1264583A Active aloe powder and preparing process thereof
08/30/2000CN1264582A Process for preparing oral liquid and powder of zinc gluconate
08/30/2000CN1055922C Lactone compound and process of prodn. thereof
08/30/2000CN1055921C Derivative of vitamin D system which is modified in 20-position, prepn. of same and pharmaceutical made of same
08/30/2000CN1055863C Health-care defatting products and its prepn. thereof
08/30/2000CN1055849C Glossy privet leaf extract with regulating blood fat and lowering blood sugar function, its separating method and use
08/29/2000US6111076 Human G-protein coupled receptor (HIBCD07)
08/29/2000US6110974 Administering optically pure eutomer of adrenergic beta-2 agonist albuterol, while minimizing or eliminating side effects residing in the corresponding distomer
08/29/2000US6110973 Methods for treating obesity and weight gain using optically pure (-)-bupropion
08/29/2000US6110964 For treating arthritis, inflammatory bowel disease, crohn's disease, emphysema, acute respiratory distress syndrome, asthma chronic obstructive pulmonary disease, alzheimer's disease, organ transplant toxicity, cachexia, cancer
08/29/2000US6110948 Treating of malignant tumor, tuberculosis, diabetes, blood dyscrasia, endocrine disease, infectious disease, or acquired immunodeficiency syndrome
08/29/2000US6110940 Salts of an anti-migraine indole derivative
08/29/2000US6110933 Amino acid derivatives and their use as phospholipase A2 inhibitor
08/29/2000US6110903 Benzimidazole inhibitors of fructose 1,6-bisphosphatase
08/29/2000US6110743 Vector having at least two oncogenes, a pair of genetic elements which are recombination sites flanking the oncogenes, and another gene; for transformed cells which produce insulin and can be transplanted into human diabetic patients
08/29/2000US6110701 DNA encoding precursor of interleukin-1β converting enzyme--related cysteine proteinase II (ICErel -II)
08/29/2000CA2010275C Pancreatic islet cell antigens obtained by molecular cloning
08/24/2000WO2000049144A2 Pyk2 binding proteins
08/24/2000WO2000049137A2 Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell
08/24/2000WO2000049043A2 Human lipid-associated proteins
08/24/2000WO2000049015A1 Pyridine compounds and their pharmaceutical use
08/24/2000WO2000049014A1 Process for the production of tert-butyl (e)-(6-[2- [4-(4-fluorophenyl) -6-isopropyl-2-[ methyl (methylsulfonyl) amino] pyrimidin-5-yl] vinyl](4r, 6s)-2,2-dimethyl [1,3]dioxan-4-yl) acetate
08/24/2000WO2000049007A1 Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s
08/24/2000WO2000048989A1 Mevinolin derivatives
08/24/2000WO2000048987A1 Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
08/24/2000WO2000048983A1 Soluble double metal salt of group ia and iia of (-) hydroxycitric acid
08/24/2000WO2000048632A1 Novel redox clamping agents and uses thereof
08/24/2000WO2000048623A1 Novel amide derivatives as growth hormone secretagogues
08/24/2000WO2000048591A1 Combinations for the treatment of diseases involving angiogenesis
08/24/2000WO2000048586A1 Remedies
08/24/2000WO2000023100A9 Genes and proteins predictive and therapeutic for renal disease and associated disorders
08/24/2000WO2000020434A9 Cadherin-like asymmetry protein-1, and methods for its use
08/24/2000WO2000010611A3 Drug targeting
08/24/2000WO1996012697A9 Calcium receptor-active compounds
08/24/2000DE19907385A1 New 3-(phenoxy or phenylalkoxy)-2-phenyl-propylamines, useful for treating e.g. arrhythmia, spasms, pain or neurodegenerative diseases, are tension-dependent sodium channel blockers
08/24/2000DE19859771C1 Wasserlösliche, stabile Brenztraubensäure(-salze)-enthaltende Formulierung Water-soluble, stable pyruvic acid (salts) -containing formulation
08/24/2000CA2362943A1 Pyk2 binding proteins
08/24/2000CA2362787A1 Novel redox clamping agents and uses thereof
08/24/2000CA2362538A1 Secreted proteins and polynucleotides encoding them
08/24/2000CA2362300A1 Human lipid-associated proteins
08/24/2000CA2362290A1 Novel amide derivatives as growth hormone secretagogues
08/24/2000CA2262056A1 Composition, methods and reagents for the synthesis of a soluble form of human pex
08/23/2000EP1029545A2 Composition for oral administration of nutritional supplement or medicaments in tablet form
08/23/2000EP1029540A2 Use of droloxifene for the treatment of cardiovascular diseases
08/23/2000EP1028958A1 Arylpiperazines as serotonin reuptake inhibitors and 5-ht1d alpha antagonists
08/23/2000EP1028956A1 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
08/23/2000EP1028955A1 Pyrimidinone compounds and pharmaceutical compositions containing them
08/23/2000EP1028948A1 Phenyl-alkyl-imidazoles as h3 receptor antagonists
08/23/2000EP1028947A1 H3 receptor ligands of the phenyl-alkyl-imidazoles type
08/23/2000EP1028945A1 Substituted pyridine compounds as anti-inflammatory agents
08/23/2000EP1028733A1 Use of mixtures of active agents containing phytostenol for producing hypocholesteraemic preparations
08/23/2000EP1028732A1 Use of selected phytostenol esters for producing hypocholesteraemic preparations
08/23/2000EP1028730A1 Compositions of lipid lowering agents
08/23/2000EP1028717A2 Unsubstituted polydiallylamine for treating hypercholesterolemia
08/23/2000EP1028709A1 Novel once-a-day controlled release sulfonylurea formulation
08/23/2000EP0844873A4 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same